Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV

Transfusion

Volumn 44, Issue 2, 2004, Pages 275-281

  Orton, Sharyn L ^a   Stramer, S L ^b   Dodd, R Y ^b   Alter, M J ^b  

^a Division of Blood Applications   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OCCUPATIONAL EXPOSURE; PERINATAL PERIOD; QUESTIONNAIRE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS DIAGNOSIS;

ADOLESCENT; ADULT; BLOOD DONORS; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; RISK FACTORS; RNA, VIRAL;

EID: 1242277288     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.00623.x     Document Type: Article

References (22)

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med, 1996;334: 1685-90.
2. Dodd RY, Notari EP 4th, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002;42:975-9.
3. Conry-Cantilena C, Van Raden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C infection. N Engl J Med, 1996;334:1691-6.
4. Murphy EL, Bryzman SM, Glynn SA, et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology 2000;31:756-62.
5. Moore SB, Kruger JR, Rakela J, et al. Blood donors who are repeatedly reactive for hepatitis C virus on enzyme immunoassay and positive on recombinant immunoblot assay: evidence of failure to identify some risk factors. Transfusion 1995;35:308-12.
6. Chamberland ME, Petersen LR, Munn VP, et al. Human immunodeficiency virus infection among health care workers who donate blood. Ann Intern Med 1994;121: 269-73.
7. Alter MJ, Hadler SC, Judson FN, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990;264:2231-5.
8. Alter MJ. Prevention of spread of hepatitis C. Hepatology 2002;36(5 Suppl 1):S93-8.
9. Beltrami EM, Kozak A, Williams IT, et al. Virus from a nursing home patient to a health care worker. Am J Infect Control 2003;31:168-75.
10. Mishra G, Sninsky C, Roswell R, Fitzwilliams S, Hyams KC. Risk factors for hepatitis C virus infection among patients receiving health care in a Department of Veterans Affairs hospital. Dig Dis Sci 2003;48:815-20.
11. Gunn RA, Murray PJ, Brennan CH, et al. Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project. Sex Transm Dis 2003;30:340-4.
12. Williams AE, Thomson RA, Schreiber GB, et al. Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. J Am Med Assoc 1997;277:967-72.
13. Conry-Cantilena C, Melpolder JC, Alter HJ. Intranasal drug use among volunteer whole-blood donors: results of Survey C. Transfusion 1998;38:512-3.
14. Haley RW, Fischer RP. Commercial tattooing as a potentially important source of hepatitis C infection: clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore) 2001;80: 134-51.
15. Busch MP, Kleinman SH, Jackson B, et al. Committee Report. Nucleic acid amplification testing of blood donors for transfusion-transmitted diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion 2000;40:143-59.
16. Durand F, Beauplet A, Marcellin P. Evidence of hepatitis C viremia without detectable antibody to hepatitis C virus in a blood donor. Ann Intern Med 2000;133:74-5.
17. Williams IT, Gretch D, Fleenor M, et al. Hepatitis C virus RNA concentration and chronic hepatitis in a cohort of patients followed after developing acute hepatitis C. In: Margolis HS, Alter MJ, Liang TJ, Dienstag JL, editors. Viral hepatitis and liver disease. Atlanta: International Medical Press; 2002: 341-4.
18. Alter MJ, Gerety RJ, Smallwood LA, et al. Sporadic non A, non B hepatitis: frequency and epidemiology in an urban United States population. J Infect Dis 1982;145:886-93.
19. Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology 2002;36(5 Suppl 1):S99-105.
20. Willis G. The cognitive aspects of responses to sensitive survey questions. Cognitive Methods Staff Working Papers, No. 9. Hyatsville (MD): National Center for Health Statistics; 1994:40-6.
21. Willis G. The use of the psychological laboratory to study sensitive survey topics: can cognitive techniques supplement field study? Cognitive Methods Staff Working Papers, No. 20. Hyatsville (MD): National Center for Health Statistics; 1996:25-33.
22. Larke B, Hu YW, Krajden M, et al. Acute nosocomial HCV infection detected by NAT of a regular blood donor. Transfusion 2002;42:759-65.